NCT01864083 FACBC PET and PEM as a Staging Tool and Indicator of Therapeutic Response in Breast Cancer Patients Status COMPLETED Phase EARLY_PHASE1
NCT01862315 Hepatic Arterial Infusion (HAI) With Floxuridine (FUDR) and Dexamethasone (Dex) Combined With Systemic Gemcitabine and Oxaliplatin in Patients With Unresectable Intrahepatic Cholangiocarcinoma (ICC) Status COMPLETED Phase PHASE2
NCT01860937 T-Lymphocytes Genetically Targeted to the B-Cell Specific Antigen CD19 in Pediatric and Young Adult Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01856543 Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation Status COMPLETED Phase PHASE3
NCT01840592 Sorafenib Plus Doxorubicin in Patients With Advanced Hepatocellular Carcinoma With Disease Progression on Sorafenib Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01840566 High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT01836341 Afatinib In Combination With Cisplatin Or Carboplatin + Pemetrexed In Patients With EGFR-Mutant Lung Cancers Undergoing Definitive Chemoradiation Status WITHDRAWN Phase PHASE1
NCT01833143 Bortezomib in KRAS-Mutant Non-Small Cell Lung Cancer in Never Smokers or Those With KRAS G12D Status COMPLETED Phase PHASE2
NCT01830582 Advanced MR Imaging for Early Biologic Tumor Changes to Neoadjuvant Chemoradiation Treatment for Rectal Cancer Status COMPLETED Phase NA
NCT01829984 Verbal and Written Instruction Versus Verbal and Written Plus Simulation in Patients With Breast Cancer and Their Caregivers Status COMPLETED Phase N/A
NCT01829958 Comprehensive Geriatric Assessment to Predict Toxic Events in Older Patients With Non-Hodgkin Lymphoma With Imbedded Pilot Study of Pre-Phase Therapy Status ACTIVE_NOT_RECRUITING Phase NA
NCT01828034 First Line Gemcitabine, Cisplatin and MEK162 in Advanced Biliary Tract Carcinoma Status COMPLETED Phase PHASE1/PHASE2
NCT01827163 Paclitaxel With Trastuzumab and Lapatinib in HER2-Positive Early Stage Breast Cancer Status COMPLETED Phase PHASE2
NCT01827137 WT1 Vaccine Treatment of Patients With Multiple Myeloma After Autologous Stem Cell Transplantation Status COMPLETED Phase PHASE1/PHASE2
NCT01826227 Intraoperative Detection of Lesions Using PET (Positron Emission Tomography) Probe During Secondary Cytoreductive Surgery for Recurrent Ovarian, Fallopian Tube and Primary Peritoneal Cancer Status COMPLETED Phase NA
NCT01815359 ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01813370 A Registry for Patients Treated on the Clinical Trial TAX 3503 Status COMPLETED Phase N/A
NCT01811862 Acupuncture for Symptom Control in Hematopoietic Stem Cell Transplantation Patients Status COMPLETED Phase NA
NCT01805609 Training Model to Advance Support of the Family as a Caregiving System in the Inpatient Oncology Setting Status ACTIVE_NOT_RECRUITING Phase NA